Literature DB >> 31776941

A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.

Amy Wood1, Edward Chau1, Yanxi Yang1, Jin Ryoun Kim2.   

Abstract

Aggregation of an amyloid protein, α-synuclein (αS), is a critical step in the neurodegenerative pathway of Parkinson's diseases (PD). Specific detection of amyloid conformers (i.e., monomers, oligomers, and fibrils) produced during αS aggregation is critical in better understanding a molecular basis of PD and developing a diagnostic tool. While various molecular probes are available for detection of αS fibrils, which may serve as a reservoir of toxic αS aggregate forms, these probes suffer from limited conformer-specificity and operational flexibility. In the present study, we explored the potential of non-self-aggregating peptides derived from the highly aggregation-prone KLVFFAE region of an amyloid protein, β-amyloid, as molecular probes for αS aggregates. We show that of the four peptides tested (KLVFWAK, ELVFWAE, and their C-terminal capping variants, all of which were attached with fluorescein isothiocyanate at their respective N-termini), KLVFWAK with C-terminal capping was selectively bound to αS fibrils over monomers and oligomers and readily used for monitoring αS fibrilization. Our analyses suggest that binding of the peptide to αS fibrils is mediated by both electrostatic and hydrophobic interactions. We anticipate that our peptide can readily be optimized for conformer-specificity and operational flexibility. Overall, this study presents the creation of a KLVFFAE-based molecular probe for αS fibrils and demonstrates fine-tuning of its conformer-specificity by terminal mutations and capping.

Entities:  

Keywords:  Amyloid aggregation; Fibril; Peptide probe; Protein engineering; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 31776941      PMCID: PMC7289322          DOI: 10.1007/s12010-019-03197-6

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  47 in total

1.  The E46K mutation in alpha-synuclein increases amyloid fibril formation.

Authors:  Eric A Greenbaum; Charles L Graves; Amanda J Mishizen-Eberz; Michael A Lupoli; David R Lynch; S Walter Englander; Paul H Axelsen; Benoit I Giasson
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

2.  Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.

Authors:  María Soledad Celej; Rabia Sarroukh; Erik Goormaghtigh; Gerardo D Fidelio; Jean-Marie Ruysschaert; Vincent Raussens
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

Review 3.  Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases.

Authors:  G Brent Irvine; Omar M El-Agnaf; Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 4.  Evolution of phage display technology: from discovery to application.

Authors:  Leila Rahbarnia; Safar Farajnia; Hossein Babaei; Jafar Majidi; Kamal Veisi; Vahideh Ahmadzadeh; Bahman Akbari
Journal:  J Drug Target       Date:  2016-11-21       Impact factor: 5.121

Review 5.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

Authors:  Matthew Biancalana; Shohei Koide
Journal:  Biochim Biophys Acta       Date:  2010-04-22

6.  The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains.

Authors:  M L Schmidt; T Schuck; S Sheridan; M P Kung; H Kung; Z P Zhuang; C Bergeron; J S Lamarche; D Skovronsky; B I Giasson; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Surface-induced aggregation of beta amyloid peptide by co-substituted alkanethiol monolayers supported on gold.

Authors:  Mariah J McMasters; Robert P Hammer; Robin L McCarley
Journal:  Langmuir       Date:  2005-05-10       Impact factor: 3.882

Review 8.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

9.  Cyanine dye-protein interactions: looking for fluorescent probes for amyloid structures.

Authors:  K D Volkova; V B Kovalska; A O Balanda; R J Vermeij; V Subramaniam; Yu L Slominskii; S M Yarmoluk
Journal:  J Biochem Biophys Methods       Date:  2007-03-30

10.  Characterization of fibrillation process of alpha-synuclein at the initial stage.

Authors:  Mitsuru Tashiro; Masaki Kojima; Hiroshi Kihara; Kouki Kasai; Tomoaki Kamiyoshihara; Kenji Uéda; Sakurako Shimotakahara
Journal:  Biochem Biophys Res Commun       Date:  2008-03-07       Impact factor: 3.575

View more
  1 in total

1.  Engineering of a protein probe with multiple inputs and multiple outputs for evaluation of alpha synuclein aggregation states.

Authors:  Edward Chau; Jin Ryoun Kim
Journal:  Biochem Eng J       Date:  2021-11-29       Impact factor: 3.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.